These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Enterococcus faecalis endocarditis successfully treated with daptomycin]. Bonnet E Med Mal Infect; 2008 Dec; 38 Spec No 2():4-6. PubMed ID: 19185201 [No Abstract] [Full Text] [Related]
4. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Munoz-Price LS; Lolans K; Quinn JP Clin Infect Dis; 2005 Aug; 41(4):565-6. PubMed ID: 16028170 [No Abstract] [Full Text] [Related]
5. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations]. Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. Vouillamoz J; Moreillon P; Giddey M; Entenza JM J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515 [TBL] [Abstract][Full Text] [Related]
7. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin. Cunha BA; Mickail N; Eisenstein L Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808 [TBL] [Abstract][Full Text] [Related]
8. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis. Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM; J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495 [TBL] [Abstract][Full Text] [Related]
9. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Segreti JA; Crank CW; Finney MS Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis. Sierra-Hoffman M; Iznaola O; Goodwin M; Mohr J Antimicrob Agents Chemother; 2012 Nov; 56(11):6064. PubMed ID: 22964255 [No Abstract] [Full Text] [Related]
12. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632 [TBL] [Abstract][Full Text] [Related]
13. [Daptomycin in the treatment of infectious endocarditis]. Tiurin VP; Serdiuk IE; Kushenko IP; Lashenkova N; Gaĭdukova IA Klin Med (Mosk); 2012; 90(4):63-6. PubMed ID: 22896985 [TBL] [Abstract][Full Text] [Related]
14. A febrile neutropenic patient with Enterococcus gallinarum sepsis treated with daptomycin and gentamicin. Barber GR; Lauretta J; Saez R Pharmacotherapy; 2007 Jun; 27(6):927-32. PubMed ID: 17542774 [TBL] [Abstract][Full Text] [Related]
15. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE). Mohr JF; Friedrich LV; Yankelev S; Lamp KC Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin. Anastasiou DM; Thorne GM; Luperchio SA; Alder JD Int J Antimicrob Agents; 2006 Nov; 28(5):385-8. PubMed ID: 17046205 [TBL] [Abstract][Full Text] [Related]
17. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan. Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793 [TBL] [Abstract][Full Text] [Related]
18. Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline. Sakoulas G; Nonejuie P; Nizet V; Pogliano J; Crum-Cianflone N; Haddad F Antimicrob Agents Chemother; 2013 Aug; 57(8):4042-5. PubMed ID: 23689728 [TBL] [Abstract][Full Text] [Related]
19. Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia. McDonald GR J Tenn Med Assoc; 1993 Dec; 86(12):527-8. PubMed ID: 8295423 [No Abstract] [Full Text] [Related]